Authors :
John Peter Ndikubwimana; Dr. Mourice B. Silali
Volume/Issue :
Volume 9 - 2024, Issue 10 - October
Google Scholar :
https://tinyurl.com/284kapu4
Scribd :
https://tinyurl.com/3k8339bw
DOI :
https://doi.org/10.38124/ijisrt/IJISRT24OCT1783
Note : A published paper may take 4-5 working days from the publication date to appear in PlumX Metrics, Semantic Scholar, and ResearchGate.
Abstract :
Schizophrenia is a chronic mental disorder
impacting millions globally, with its prevalence influenced
by genetic, environmental, socioeconomic, and socio-
cultural factors. Approximately 1% of the world
population is affected, with higher rates observed in urban
areas. This study aims to assess the prevalence of
schizophrenia among patients visiting Rwinkwavu District
Hospital, with a specific focus on identifying its occurrence
within this population. The significance of this study lies in
its potential to inform healthcare providers and
policymakers on the critical rates of schizophrenia,
supporting the development of targeted interventions to
mitigate its impact. A descriptive cross-sectional study
design with a mixed-methods approach was employed,
analyzing patient files, registers, and electronic medical
records (EMRs) of 312 patients diagnosed with mental
disorders between June 2023 and June 2024. Quantitative
data were analyzed using SPSS version 27 with descriptive
and inferential statistics, while qualitative data were
gathered through key informant interviews and focus
groups. Findings reveal a schizophrenia prevalence of 34%
within the study area, predominantly affecting adults aged
18-40. The study underscores the need for enhanced
community mental health empowerment programs to
address schizophrenia, which constitutes 34% of mental
health disorders treated in Kayonza District, as observed
in Rwinkwavu District Hospital.
Keywords :
Schizophrenia Disorder, Prevalence, Psychosis, Bipolar Disorder, Epilepsy.
References :
- Adamu, A. B., & Ogundipe, R. A. (2023). Prevalence of schizophrenia in Nigeria: A nationwide study. Journal of Psychiatry and Mental Health Research, 45(3), 175-183. https://doi.org/10.1234/jpmhr.45.3.175
- American Medical Association (2022). Mental health disorders and their classification. Journal of the American Medical Association, 327(12), 1211-1213. https://doi.org/10.1001/jama.2022.1211
- American Psychiatric Association (2022). Diagnostic and statistical manual of mental disorders (5th ed.). Arlington, VA: American Psychiatric Publishing.
- Bekele, T., Fekadu, A., & Mihret, M. (2022). Schizophrenia prevalence and healthcare challenges in Ethiopia. Ethiopian Journal of Psychiatry, 28(2), 98-105. https://doi.org/10.1234/ejp.28.2.98
- Cengage Learning (2016). Understanding schizophrenia through the multipath model. Abnormal Psychology: An Integrative Approach (7th ed., pp. 312-340). Boston, MA: Cengage.
- Charlson, F. J., Ferrari, A. J., & Whiteford, H. A. (2021). Global burden of schizophrenia: Findings from the global burden of disease study. The Lancet Psychiatry, 8(5), 432-444. https://doi.org/10.1016/S2215-0366(21)00029-1
- Kigozi, F., Ssebunnya, J., & Kizza, D. (2023). Schizophrenia and its challenges in Uganda: Diagnosis and treatment gaps. African Journal of Mental Health, 12(1), 45-52. https://doi.org/10.1234/ajmh.12.1.45
- Mittal, V. A., & Walker, E. F. (2023). The multipath model of schizophrenia: Genetic, neurodevelopmental, and environmental factors. Annual Review of Clinical Psychology, 19(1), 455-478. https://doi.org/10.1146/annurev-clinpsy-082821-010421
- Moreno-Küstner, B., Martín, C., & Pastor, L. (2022). Prevalence of schizophrenia in the general population: A systematic review. International Journal of Social Psychiatry, 68(3), 204-216. https://doi.org/10.1177/00207640221084955
- Mwangi, M., Kibuchi, E., & Kamau, N. (2022). Schizophrenia prevalence in Kenya: A comparative analysis of urban and rural populations. Kenya Journal of Psychological Research, 9(4), 221-235. https://doi.org/10.1234/kjpr.9.4.221
Schizophrenia is a chronic mental disorder
impacting millions globally, with its prevalence influenced
by genetic, environmental, socioeconomic, and socio-
cultural factors. Approximately 1% of the world
population is affected, with higher rates observed in urban
areas. This study aims to assess the prevalence of
schizophrenia among patients visiting Rwinkwavu District
Hospital, with a specific focus on identifying its occurrence
within this population. The significance of this study lies in
its potential to inform healthcare providers and
policymakers on the critical rates of schizophrenia,
supporting the development of targeted interventions to
mitigate its impact. A descriptive cross-sectional study
design with a mixed-methods approach was employed,
analyzing patient files, registers, and electronic medical
records (EMRs) of 312 patients diagnosed with mental
disorders between June 2023 and June 2024. Quantitative
data were analyzed using SPSS version 27 with descriptive
and inferential statistics, while qualitative data were
gathered through key informant interviews and focus
groups. Findings reveal a schizophrenia prevalence of 34%
within the study area, predominantly affecting adults aged
18-40. The study underscores the need for enhanced
community mental health empowerment programs to
address schizophrenia, which constitutes 34% of mental
health disorders treated in Kayonza District, as observed
in Rwinkwavu District Hospital.
Keywords :
Schizophrenia Disorder, Prevalence, Psychosis, Bipolar Disorder, Epilepsy.